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Abstract 
Purpose: Purpose: To determine TEM-116 beta-lactamase gene prevalence in drug-resistant 
Pseudomonas aeruginosa isolates from Pakistan. 
Methods: Sequence analysis of TEM beta-lactamase isolates and their antibiotic susceptibility patterns 
were carried out. Quantitative bacteriostatic concentrations for commonly used antibiotics were 
measured against TEM-116 beta-lactamase isolates.  
Results: Among the 102 isolates of P. aeruginosa, 23 (22.5 %) were TEM beta-lactamase producers. 
Sequence analysis of TEM gene from selected isolates showed homology with TEM-116. Two 
mutations at positions 84 (p.Val84Ile) and 184 (p.Ala184Val) were documented. The TEM-116 isolates 
exhibited 100 % resistance to sulphamethoxazole/trimethoprim, amoxycillin/clavulanic acid and 
doxycycline, but showed sensitivity to levofloxacin, norfloxacin and amikacin. One TEM-116 P. 
aeruginosa (PA11) isolate was resistant to all available antibiotics. 
Conclusion: These results reveal increased antibiotic resistance in the TEM-116 P. aeruginosa isolates 
studied, a phenomenon which will be helpful in understanding the molecular mechanisms of antibiotic 
resistance in P. aeruginosa. 
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P. aeruginosa is the leading cause of nosocomial 
infections in immuno-compromised patients in 
hospitals. The frequency of P. aeruginosa 
infections is high in burn patients due to easier 
access of pathogens [1]. Emergence of 
antibiotics resistance in P. aeruginosa is a major 
public health concern because the resistant 
organisms produce a wide range of beta 
lactamases. Production of extended spectrum 
beta lactamases (ESBLs) is the principle 
mechanism involved in coping with antibiotics by 
P. aeruginosa [2]. The recent increase in ESBLs 
production by P. aeruginosa is alarming in 
developing countries due to non-judicious 
use/abuse of antibiotics. This practice engenders 
new modes of resistance while augmenting the 
prevalence of drug-resistant bacteria [3-5]. 
Among the ESBLs, TEM-1 beta-lactamase was 
first identified in E. coli and later-on in P. 
aeruginosa [6,7]. TEM-1 is the most commonly 
encountered beta-lactamase in Gram-negative 
bacteria. Up to 90 % of ampicillin resistance in E. 
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coli is due to the production of beta-lactamase by 
TEM-1 gene. TEM-2, the first derivative of TEM-
1, has a single amino acid substitution from the 
original beta-lactamase [8,9]. Characterization of 
beta-lactamases in drug-resistant P. aeruginosa 
will be crucial in the study of mechanisms of 
molecular pathogenesis and virulence. 
 
The present study was undertaken to screen and 
identify TEM beta lactamases among clinical 
isolates of P. aeruginosa in Pakistan. Moreover, 
antibiotic susceptibility was performed in TEM 




The study was conducted at the Department of 
Biotechnology and Genetic Engineering, Kohat 
University of Science and Technology, Kohat, 
Pakistan. Samples totalling 102 were collected 
from a tertiary care hospital, Peshawar, Khyber 
Pakhtunkhwa, Pakistan and aseptically 
transported to the research laboratory. 
 
Pure culture of P. aeruginosa isolates  
 
In our previous study, a total of 102 isolates were 
identified as P. aeruginosa on the basis of 
phenotypic and species specific PCR [10]. Pure 
cultures of P. aeruginosa were processed for this 
study. All the isolates were re-confirmed by 
biochemical assays using standard protocols. 
 
Molecular detection of TEM beta-lactamase in 
P. aeruginosa 
 
TEM gene amplification was checked in all 102 
isolates of P. aeruginosa. Primers used were as 
follows: TEM forward 5׳-TCGGGGAAATGTGCG-
 TGCTTAATCAGTGA-׳and TEM reverse 5 ׳3
GGCACC-3׳primers [8]. Ready PCR mixture 
contained 10 mM Tris HCl, 50 mM KCl, 1.5 mM 
MgCl2, 0.5 mM DDT, glycerol, Gelatin, NP-40, 
0.05 mM Tween-20, 0.2 mM dNTPs and Taq 
DNA polymerase. 1 µL genomic DNA was used 
for every reaction in a total volume of 25 µL. The 
following PCR conditions were used for TEM 
gene amplification of P. aeruginosa: initial 
denaturation at 95 oC for 5min followed by 35 
cycles, 94 oC for 1 min, 58 oC for 1 min, 72 oC for 
1 min and final extension for 7 min. The amplified 
product was separated on agarose gel and 
visualized under UV trans-illuminator.  
 
Sequencing of amplified TEM gene and 
bioinformatics analysis 
 
Amplified PCR product was sequenced using 
forward primer for the TEM gene. Sequencing 
reactions were performed by Macrogen (Seoul) 
Korea. Online available Bioedit software was 
used for sequence analysis. Amino acid 
sequence of TEM was analysed on translation 
tool (www.expasy.org/) and was matched with all 
previously reported TEM genes [11]. 
 
Antibiotic susceptibility assay of TEM-116 
beta-lacatamase-producing P. aeruginosa 
 
Antibiotic sensitivity pattern of TEM-116 beta-
lactamase producing P. aeruginosa isolates were 
determined by modified Kirby-Bauer method [12]. 
A 0.5 McFarland dilution of refreshed bacterial 
isolate was inoculated on Mueller Hinton agar 
(MHA). Antibiotic discs (Oxoid, UK) including 
amoxycillin/clavulanic acid (AMC), aztreonam 
(ATM), ceftazidime (CAZ), cefepime (FEP), 
imipenem (IPM)  ceftriaxone (CRO), amikacin 
(AK), doxycycline (DO), gentamicin (CN), 
ciprofloxacin (CIP), norfloxacin (NOR), 
levofloxacin (LEV), 
sulphamethoxazole/trimethoprim (SXT), sulzone 
(SCF) and chloramphenicol (C)  were placed on 
MHA plates and then incubated overnight. After 
incubation, zones of inhibition were measured 
and interpreted in accordance with Clinical 





Quantitative minimum inhibitory concentrations 
(MICs) of the selected antibiotics (including 
ciprofloxacin, ceftriaxone, gentamicin and 
amikacin) against TEM 116 beta-lacatamse- 
producing P. aeruginosa were evaluated by E-
test in accordance with manufacturer’s 




Among the 102 P. aeruginosa isolates, the 
amplified product of 972 bp corresponding to 
TEM gene size was found in 23 isolates (22.5 %) 
(Figure 1). 
 
TEM amplified gene product was processed for 
sequencing. When nucleotide sequence was 
translated into amino acids, it showed 100 % 
amino acid sequence homology with TEM 116. In 
chromatogram the nucleotides at position 
c.250G>A and c.551C>T, refer to the substituted 
nucleotides and p.Val84Ile and p.Ala184Val refer 
to the amino acids substitutions at these two 
positions in comparison to the original TEM 1 
gene sequence (Figure 2).  
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Figure 1: Detection of TEM beta-lacatamase gene in P. aeruginosa: TEM gene (972bp) was specifically 
amplified and resolved on 1.8 % agarose gel. 1, 2 and 3 in the gel indicated TEM gene amplification. L: Lader, P: 






Figure 2: Chromatogram of the sequenced data showing mutation in nucleotides at positions 250 and 551 for the 
corresponding amino acids Ile and Val in TEM 116 
 
BLAST analysis of the translated amino acids 
sequence with TEM 1, showed two mutations 
that include replacement of valine by isoleucine 
at position 84, and replacement of alanine by 
valine at position 184 (Table 1). The two 
mutations at positions 84 and 184 confirmed the 
presence of TEM-116 when used online tool 
(http://www.laced.uni-stuttgart.de).  
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Table 1: Amino acid substitutions of TEM-116 




Residue (triplet code) at 
amino acid: 
  84                            184 
TEM-1 Val (GTT) Ala (GCA) 
TEM-116 Ile (ATT) Val (GTA) 
 
After analysis of sequence homology, the TEM-
116 beta-lactamase producing isolates were 
processed for antibiotic susceptibility pattern. 
The TEM-116 isolates showed 100 % resistance 
(n = 7) to sulphamethoxazole/trimethoprim, 
amoxycillin/clavulanic acid and doxycycline. 
However they showed increased sensitivity to 
levofloxacin, norfloxacin and amikacin. One 
isolate, PA11 showed resistance to all the 
antibiotics used in the study (Table 2). 
 
MICs were determined to assess the quantitative 
inhibitory concentration of commonly used 
antibiotics against TEM producing P. aeruginosa. 
It was found that MIC of ceftriaxone was >512 
µg/ml against three isolates (PA5, PA9 and 
PA11) while PA11 isolate was found to be the 
most resistant among all TEM-116 producing 




Resistance to beta-lactam antibiotics in 
communities and hospitals has created a major 
health problem leading to increased mortality, 
morbidity and high health care expenses.  
 
Production of extended spectrum beta-
lactamases (ESBLs) in bacteria is the principle 
mechanism of resistance against beta-lactam 
antibiotics. Among ESBLs, TEM beta-lactamase 
family has variable diversity, prevalence and 
global distribution [11]. In TEM family, TEM-116 
was first reported among Enterobacteriaceae in 
Korea [14] and in P. fluorescens [15]. One study 
has documented co-production of TEM-116 and 
SHV-2a in P. aeruginosa isolates in France 
[16].In the present study, TEM-116 showed two 
point mutations which cause amino acid 
substitution from valine to isoleucine at position 
84 and alanine to valine at position 184. Similar 
mutations in TEM 116 were also reported in P. 
fluorescens [15]. 
 
When antibiotic susceptibility pattern was 
checked, it was found that TEM 116-producing P. 
aeruginosa isolates exhibited maximum 
resistance to sulphamethoxazole/trimethoprim, 
amoxycillin/clavulanic acid and doxycycline. In 
several studies, ESBLs and TEM 116 isolates 
were highly resistant to commonly available 
antibiotics [16-18]. These reports are   in line with 
our findings. Moreover TEM-116 producers in the 
current study exhibited sensitivities to 
levofloxacin, norfloxacin and amikacin, which 
indicate effective bacteriostatic activity against 
the TEM-116 isolates. When bacteriostatic 
activities of selected antibiotics including 
ciprofloxacin, ceftriaxone, gentamicin and 
amikacin were checked, they showed similar 
variable activities as reported earlier [17]. 
 










AMC NOR AK DO FE
P 
ATM 
PA1 R R S S R R R R R R R R R R R 
PA2 R R R R S R R R R R R R R R R 
PA3 S S S S R S S R S R S S R S S 
PA5 R S R R R R R R S R R S R R R 
PA9 S R R R R S S R I R S S R R R 
PA11 R R R R R R R R R R R R R R R 
PA20 S I R R R R R R R R S R R R R 
R; resistance, I; intermediate, S; sensitive 
 
Table 3: MIC of selected antimicrobial agents against TEM 116 producing Pseudomonas aeruginosa isolates 
 
Isolate Antibiotic MIC (µg/ml) 
Ciprofloxacin Ceftriaxone Gentamicin Amikacin 
PA1 ≤8 16 128 64 
PA2 32 64 128 128 
PA3 1 16 ≤8 ≤8 
PA5 128 >512 >512 256 
PA9 32 >512 ≤8 ≤8 
PA11 >512 >512 >512 >512 
PA20 ≤0.5 32 128 16 
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Among these isolates (PA11) showed resistance 
to all the antibiotics used in the study. The 
possible reason might be the presence of full 
spectrum of beta lactamases and other virulence 




In the present study, increased antibiotic 
resistance was reported in the TEM-116 P. 
aeruginosa isolates from Pakistan. These 
findings are considered beneficial in 
understanding the mechanism(s) involved in 
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